Entero Therapeutics Discounted Cash Flow

Entero Therapeutics (ENTO) currently reports a DCF fair value of $0.0067. Use the charts on this page to explore Entero Therapeutics's DCF fair value history and peer comparisons.

Entero Therapeutics's discounted cash flow (DCF) fair value estimate is $0.0067, about 99.8% overvalued versus the current market price. DCF models project future free cash flows and discount them back to today — so the result depends on growth, margin, and discount-rate assumptions. Use it as one valuation lens alongside multiples and peer checks on Stockcircle.

Start with the current DCF fair value of $0.0067, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Entero Therapeutics, and consider following ENTO for alerts when major investors trade the stock.